• No results found

Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll like receptor 4

N/A
N/A
Protected

Academic year: 2020

Share "Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll like receptor 4"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Clinical and demographic characteristics of OApatients whose synovial fluid was analyzed with massspectrometry
Table 2 Proteins identified in OA synovial fluids in this study and in a previous proteomic study [10]
Table 3 Proteins newly identified in OA synovial fluids
Table 4 Classes of proteins newly identified in OA synovial fluids
+6

References

Related documents

Among a large case series in people, it was reported that a spectrum of presenting clinical signs could be associated with histoplasmosis, and this had implications for delays

In an effort to improve IS 6110 -based RFLP to make it a faster format, DuPont Molecular Diagnostics recently introduced the IS 6110 -PvuII kit for semiautomated typing of

The results obtained through analysis of water samples from Bore wells of five villages (vadugapalayam, pothiyampalaym, ponnandampalayam, sellapampalayam and

The data mining process of extracting information from large set database. Mining has attracted great attention from various fields due to wide and large data present in these

Hence TFL optimization methodology was employed to optimize input process parameters in Laser Micro-Machining while machining Hastelloy C276 considering the input process

The results show that specific viscosity of CuDC and CrDC initially increases with increase in complex concentration and then decreases which corresponds to the CMC of the

The gain is calculated as ratio of output voltage at receiver end and input voltage at transmitter (Fig. At around 50 kHz the response time of the photodiode is no longer

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy